Published in TB and Outbreaks Week, January 9th, 2001
"Human respiratory syncytial virus (RSV) is the primary cause of respiratory infection in infants worldwide. Currently there is no available vaccine, although studies in animal models have demonstrated protective immunity induced by an epitope of the RSV G-protein representing amino acids 174-187," wrote H. Belanger and colleagues ("Human respiratory syncytial virus vaccine antigen produced in plants," FASEB Journal, 2000;14(14):2323-2328).
"Two peptides containing amino acids 174-187 of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week